Adam S. Grossman, President and CEO at ADMA BIOLOGICS, INC. (ADMA), sold 97,934 shares at $21.10 ($2.1M) on 2024-11-22, disclosed to the SEC on 2024-11-22.
Open-market sale of $2.1M ADMA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.10 | 48,967 | $1.0M | 50.0% |
| 2 | $21.10 | 48,967 | $1.0M | 50.0% |
| Total | $21.10 avg | 97,934 | $2.1M | 100% |
| Filing → |
| ADMA | SELL | 2025-12-16 | $416K | — | Filing → |
| ADMA | SELL | 2025-11-21 | $336K | — | Filing → |
| ADMA | SELL | 2025-10-24 | $336K | — | Filing → |